Newcleo intends to list on Nasdaq via a SPAC to raise up to $429 million for its lead-cooled fast reactors. The company is shifting its deployment site from France to the US to secure plutonium more easily and expedite licensing. This move is contingent on the US DOE's surplus plutonium utilization program.
Sign in to access complete coverage, AI analysis, and related companies.
Sign In to Continue